TLSATiziana Life Sciences (NASDAQ:TLSA) bounced nicely off the rising EMA9 again on volume. Based on the chart and price action, I think the stock should test its declining EMA200 very soon. This COVID play should be kept on watch.
TLSA trade ideas
$TLSA Target 3.91 for 41.67% $TLSA Target 3.91 for 41.67%
Or next add level is at 1.61
—
On the far right of the chart is my Average (Grey) Current Target (Green), and Next Level to add (Red) Percentage to target is from my average.
I start every position with 1% of my account and build from there as needed and as possible.
I am not your financial advisor. Watch my setups first before you jump in… My trade set ups work very well and they are for my personal reference and if you decide to trade them you do so at your own risk. I will gladly answer questions to the best of my knowledge but ultimately the risk is on you. I will update targets as needed.
GL and happy trading.
$TLSA Target 4.82 for 31.34% LET'S GO$TLSA Target 4.82 for 31.34%
Or next add level is at 2.52
—
On the far right of the chart is my Average (Grey) Current Target (Green), and Next Level to add (Red) Percentage to target is from my average.
I start every position with 1% of my account and build from there as needed and as possible.
I am not your financial advisor. Watch my setups first before you jump in… My trade set ups work very well and they are for my personal reference and if you decide to trade them you do so at your own risk. I will gladly answer questions to the best of my knowledge but ultimately the risk is on you. I will update targets as needed.
GL and happy trading.
$TLSA is gonna fall todayPupm&Dump trading strategy idea.
$TLSA is rising too much today.
The demand for shares of the company looks lower than the supply.
This and other conditions can cause a fall in the share price today.
So I opened a short position from $5,65;
stop-loss — $6,50;
take-profit — $4,00;
Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision.
Always do your own analysis before making deals. When you use any materials, do not rely on blind trust.
You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy.
If you like my content, you can subscribe to the news and receive my fresh ideas.
Thanks for being with me!
TLSA - PLAYING THE WEDGE GAMEPossible entry 3.52/3.55 on a trending support hold
Okay, here's a possible move play! Favorable trading and charting conditions in my opinion. Why?
1. Wedge formations can become parabolic signals. The highs and lows are trading inside this wedge.
2. This is an upwards trending stock, with the pricepoints holding, again inside this wedge.
3. The Stochastic indicator is suggesting a further move south. This indicator is a great source for stock sentiment. It is waning, but knowledge says to buy the oversold condition on an upwards moving stock, if volume and ema points are solid. In short, buying the discount.
4. The 8 EMA is the pivot line, like a fishing bobber, where price wants to stay near. The 34 EMA should not be a factor in this case.
*Let's see what happens
DISCLAIMER - I am not a professional trader. These are merely my thoughts and possible moves; i enjoy watching these stocks validate my process or slap me across the face lol. If you are in need of professional assistance with your trades, don't look here. I am not that guy.
Tiziana Life Sciences Plc Covid-19 TreatmentThinly traded nano cap Tiziana Life Sciences (NASDAQ:TLSA) is the latest coronavirus play. Shares are up 306% premarket on average volume in reaction to its announcement that candidate TZLS-501 may be a potential treatment for COVID-19 patients at risk of respiratory failure.
The company says it plans to administer TZLS-501, an interleukin 6 (IL-6)-inhibiting monoclonal antibody, using a proprietary formulation technology, adding that excess production of IL-6 is a key driver of chronic inflammation and is believed to play a key role in severe lung damage seen with COVID-19 infection and acute respiratory illness.
Source seekignalpha
Tiziana Life Sciences Plc is a biotechnology company, which engages in the research and development of biotechnological and pharmaceutical products. Its lead product candidate in immunology is Foralumab (TZLS-401), which is a fully human anti-CD3 monoclonal antibody. The company was founded by Gabriele Marco Antonio Cerrone on November 4, 2013 and is headquartered in London, the United Kingdom.
